Cargando…

Association between normal or mildly reduced kidney function, cardiovascular risk and biomarkers for atherosclerosis: results from the ENCORE trial

BACKGROUND: Moderate-to-severe kidney dysfunction is associated with atherosclerotic cardiovascular disease (ASCVD). Gradations of normal or mildly reduced kidney function may also associate with ASCVD risk. METHODS: We conducted a secondary analysis using baseline data from the Exercise and Nutriti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tyson, Crystal C., Smith, Patrick J., Sherwood, Andrew, Mabe, Stephanie, Hinderliter, Alan L., Blumenthal, James A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Cardiovascular Risk
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622906/ https://www.ncbi.nlm.nih.gov/pubmed/28979778 http://dx.doi.org/10.1093/ckj/sfx025

Ejemplares similares

Discovery of plasma biomarkers for predicting the severity of coronary artery atherosclerosis by quantitative proteomics
por: Ku, Eu Jeong, et al.
Publicado: (2020)

A clinical-genetic approach to assessing cardiovascular risk in patients with CKD
por: Rodrigo, Emilio, et al.
Publicado: (2017)

Effects of BMI and LDL-cholesterol change pattern on cardiovascular disease in normal adults and diabetics
por: Youk, Tae Mi, et al.
Publicado: (2020)

Diabetes, Atherosclerosis, and Stenosis by AI
por: Jonas, Rebecca A., et al.
Publicado: (2023)

Association between office visit intervals and long‐term cardiovascular risk in hypertensive patients
por: Kim, Duon, et al.
Publicado: (2023)

Relationship between flow-mediated vasodilation and cardiovascular risk factors in a large community-based study
por: Maruhashi, Tatsuya, et al.
Publicado: (2013)

A cardiovascular risk prediction model for older people: Development and validation in a primary care population
por: van Bussel, Emma F., et al.
Publicado: (2019)

Habitual intake of anthocyanins and flavanones and risk of cardiovascular disease in men(1)(2)
por: Cassidy, Aedín, et al.
Publicado: (2016)

Regression From Prediabetes to Normal Glucose Regulation Is Associated With Reduction in Cardiovascular Risk: Results From the Diabetes Prevention Program Outcomes Study
por: Perreault, Leigh, et al.
Publicado: (2014)

Interplay between worsening kidney function and cardiovascular events in patients with type 2 diabetes: an analysis from the ACCORD trial
por: Ferreira, João Pedro, et al.
Publicado: (2021)

Association of Acculturation Levels and Prevalence of Diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA)
por: Kandula, Namratha R., et al.
Publicado: (2008)

Subclinical Atherosclerosis Is Inversely Associated With Gray Matter Volume in African Americans With Type 2 Diabetes
por: Freedman, Barry I., et al.
Publicado: (2015)

Postprandial lipemia and the risk of coronary heart disease and stroke: the Atherosclerosis Risk in Communities (ARIC) Study
por: Kats, Dmitry, et al.
Publicado: (2017)

Orange juice–derived flavanone and phenolic metabolites do not acutely affect cardiovascular risk biomarkers: a randomized, placebo-controlled, crossover trial in men at moderate risk of cardiovascular disease(1)(2)(3)(4)(5)
por: Schär, Manuel Y, et al.
Publicado: (2015)

Whey protein lowers blood pressure and improves endothelial function and lipid biomarkers in adults with prehypertension and mild hypertension: results from the chronic Whey2Go randomized controlled trial(1)(2)
por: Fekete, Ágnes A, et al.
Publicado: (2016)

Relationship between serum creatinine to cystatin C ratio and subclinical atherosclerosis in patients with type 2 diabetes
por: Hashimoto, Yoshitaka, et al.
Publicado: (2022)

Association between varying cut-points of intermediate hyperglycemia and risk of mortality, cardiovascular events and chronic kidney disease: a systematic review and meta-analysis
por: Gujral, Unjali P, et al.
Publicado: (2021)

High-Sensitivity Cardiac Troponin T (hs-cTnT) as a Predictor of Incident Diabetes in the Atherosclerosis Risk in Communities Study
por: Whelton, Seamus P., et al.
Publicado: (2017)

Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study
por: Saremi, Aramesh, et al.
Publicado: (2017)

Extracellular Hsp90α, which participates in vascular inflammation, is a novel serum predictor of atherosclerosis in type 2 diabetes
por: Ding, Xinyi, et al.
Publicado: (2022)

Metabolic characteristics of Africans with normal glucose tolerance and elevated 1-hour glucose: insight from the Africans in America study
por: Briker, Sara M, et al.
Publicado: (2020)

Antihyperglycemic Medications and Cardiovascular Risk Reduction
por: Anderson, Sarah L, et al.
Publicado: (2017)

Hispanic representation in diabetes cardiovascular outcomes trials
por: Kelley, A. Taylor, et al.
Publicado: (2019)

Increased Skeletal Muscle Capillarization After Aerobic Exercise Training and Weight Loss Improves Insulin Sensitivity in Adults With IGT
por: Prior, Steven J., et al.
Publicado: (2014)

Normal Glucose Values Are Associated With a Lower Risk of Mortality in Hospitalized Patients
por: Bruno, Alberto, et al.
Publicado: (2008)

Risk of Glucose Intolerance and Diabetes in Hemipancreatectomized Donors Selected for Normal Preoperative Glucose Metabolism
por: Kumar, Anjali F., et al.
Publicado: (2008)

Autoantibodies Against Methylglyoxal-Modified Apolipoprotein B100 and ApoB100 Peptide Are Associated With Less Coronary Artery Atherosclerosis and Retinopathy in Long-Term Type 1 Diabetes
por: Sveen, Kari Anne, et al.
Publicado: (2021)

Glycemic variability and cardiovascular disease in patients with type 2 diabetes
por: Martinez, Marcela, et al.
Publicado: (2021)

Management of type 2 diabetes in chronic kidney disease
por: Triozzi, Jefferson L, et al.
Publicado: (2021)

Lesinurad: what the nephrologist should know
por: Sanchez-Niño, Maria Dolores, et al.
Publicado: (2017)

Consequences of access to water from managed aquifer recharge systems for blood pressure and proteinuria in south-west coastal Bangladesh: a stepped-wedge cluster-randomized trial
por: Naser, Abu Mohd, et al.
Publicado: (2020)

High-throughput multivariable Mendelian randomization analysis prioritizes apolipoprotein B as key lipid risk factor for coronary artery disease
por: Zuber, Verena, et al.
Publicado: (2020)

Commentary: Big data bring big controversies: HDL cholesterol and mortality
por: Ala-Korpela, Mika, et al.
Publicado: (2021)

Statin-related Muscle Toxicity: An Evidence-based Review
por: Jeeyavudeen, Mohammad S, et al.
Publicado: (2022)

Influence of age on the prevalence and components of the metabolic syndrome and the association with cardiovascular disease
por: Devers, Marion C, et al.
Publicado: (2016)

Cardiovascular Determinants of Aerobic Exercise Capacity in Adults With Type 2 Diabetes
por: Gulsin, Gaurav S., et al.
Publicado: (2020)

Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial
por: Buse, John B., et al.
Publicado: (2020)

Impact of increased visceral adiposity with normal weight on the progression of arterial stiffness in Japanese patients with type 2 diabetes
por: Bouchi, Ryotaro, et al.
Publicado: (2015)

Impaired Succinate Response to a Mixed Meal in Obesity and Type 2 Diabetes Is Normalized After Metabolic Surgery
por: Astiarraga, Brenno, et al.
Publicado: (2020)

Increased Risk of Cardiovascular Disease in Young Women Following Gestational Diabetes Mellitus
por: Shah, Baiju R., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_j96grb41s5mm8ac8f6fjk441bq